Hepatoprotective effect and metabonomics studies of radix gentianae in rats with acute liver injury
- PMID: 34465274
- PMCID: PMC8409929
- DOI: 10.1080/13880209.2021.1969414
Hepatoprotective effect and metabonomics studies of radix gentianae in rats with acute liver injury
Abstract
Context: As a well-known traditional Chinese medicine for protecting the liver, the mechanism of Radix Gentianae (RG) remains unclear.
Objective: The hepatoprotective effect and metabonomics of RG were studied to explore the molecular and metabolic mechanisms of RG protecting the liver.
Materials and methods: Sprague-Dawley rats were divided into control and model group (n = 10, orally given distilled water), intervention group (4 subgroups, n = 10, prophylactically and orally given 0.63, 2.5 and 5.6 g/kg RG and 0.2 g/kg bifendatatum for 7 d). On day 7 of the intervention, all rats except the control were injected intraperitoneally with 2.5% carbon tetrachloride vegetable oil solution (1.5 mL/kg) to induce liver injury. After 24 h of carbon tetrachloride injection, rat serum and liver tissue were collected for determining AST, ALT, TNF-α, MCP-1, IL-6, SOD, MDA, GSH, and GSH-PX. Rat serum was used for analysing endogenous metabolism by UPLC-Q-TOF-MS.
Results: Different doses of RG can significantly decrease the levels of AST, ALT, TNF-α, MCP-1, IL-6 and MDA, and increase the levels of SOD, GSH, and GSH-PX in rats with liver injury (p < 0.05; TNF-α, and IL-6, p < 0.05 only at 5.6 g/kg dose). Eight biomarkers of liver injury were obtained in serum metabonomics, involving five significant metabolic pathways. RG can improve steroid biosynthesis, linoleic acid metabolism, porphyrin and chlorophyll metabolism, and fatty acid biosynthesis.
Conclusion: RG demonstrated a good ability to protect the liver and improving endogenous metabolism in rats with liver injury. This can help us understand the mechanism of RG and more clinical verifications were inspired.
Keywords: Gentiana; metabolic mechanism; molecular mechanism; pharmacodynamics.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures






References
-
- Chen X, Cai W, Lin J, Yu H.. 2018. Clinical observation of Xieqing pills combined with Shengjiang powder for insomnia and anxiety of syndrome of liver depression transforming into fire. J New Chin Med. 50:63–66.
-
- Chinese Pharmacopoeia Commission . 2015. Pharmacopoeia of the people’s Republic of China (Part I). Beijing: The Medicine Science and Technology Press of China.
-
- Ding J. 2020. Effects of gentiopicroside on ANIT-induced cholestasis in rats. China Pharm. 23:2133–2137.
-
- Ebrahimi-Mameghani M, Jamali H, Mahdavi R, Kakaei F, Abedi R, Kabir-Mamdooh B.. 2016. Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial. Croat Med J. 57(4):331–342. - PMC - PubMed
-
- Han H, Xu L, Xiong K, Zhang T, Wang Z.. 2018. Exploration of hepatoprotective effect of gentiopicroside on alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats by comprehensive proteomic and metabolomic signatures. Cell Physiol Biochem. 49(4):1304–1319. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous